X0206 3 2020-10-27 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001830911 MISHAN ORLY C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET, SUITE 502 BOSTON MA 02116 0 1 0 0 Chief Business Officer Stock Option (Right to Buy) 3.50 2029-06-25 Common Stock 465363 D Stock Option (Right to Buy) 10.28 2029-06-25 Common Stock 155120 D 25% of the shares subject to this option vested and became exercisable on July 15, 2020, with remainder vesting in 36 equal monthly installments thereafter. Exhibit 24 - Power of Attorney /s/ Bryan K. Phillips, as Attorney-in-Fact 2020-11-02